Larry Zoglin represents whistleblowers in a wide variety of qui tam cases against healthcare providers, defense contractors and other government contractors.
He also handles whistleblower claims filed with the Securities and Exchange Commission and the Internal Revenue Service under their whistleblower rewards programs.
- Mr. Zoglin was the lead attorney in a qui tam lawsuit that alleged skilled nursing facilities in California owned by the Ensign Group were engaged in a Medicare billing fraud scheme. The case settled for $48 million.
- He also represented a whistleblower in a qui tam lawsuit against many hospitals for allegedly inflating Medicare reimbursement claims to receive “outlier” payments. Eleven hospitals paid the government more than $44 million to settle that case.
- Mr. Zoglin was a member of the legal team that achieved record-breaking settlements from Pfizer Inc. and GlaxoSmithKline. Pfizer paid $2.3 billion to the government to settle “off-label” marketing and criminal charges. That settlement amount is second only to the $3 billion settlement Glaxo paid to settle separate “off-label” marketing and criminal charges.
Mr. Zoglin previously served as an Assistant U.S. Attorney in the Southern District of California (San Diego) for four years. He was responsible for investigations and trials for a wide range of federal crimes. He then joined Paul, Weiss, Rifkind, Wharton & Garrison, where he handled complex civil cases, including those involving antitrust issues, securities fraud and international trade disputes.
Mr. Zoglin graduated second in his class from New York University School of Law, which he attended on a full scholarship (through the Root-Tilden Public Interest Law Award) to study law in the public interest. At law school, he was a member of the Order of the Coif. In 1978, he also earned a Masters of Public and International Affairs from the Woodrow Wilson School of Public Affairs at Princeton University.
In 1986, Mr. Zoglin was awarded a Fulbright Research Fellowship to study insider trading in the Japanese securities market. He returned to Japan in 1989, where he studied at a Zen Buddhist monastery for 11 years.
Mr. Zoglin is admitted to the bar in California and Washington, DC.